{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-275897","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.804097+00:00","generated_at":"2026-06-22T16:20:59.491347+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sarepta EVP Technical Ops resigns, Bilal Arif appointed as replacement","bullets":["William F. Ciambrone to resign as EVP Technical Operations effective Dec 31, 2022.","Ciambrone to consult through Q2 2023 at $500/hour; equity continues vesting.","Board appointed Bilal Arif as Chief Technical Operations Officer effective Dec 31, 2022.","Resignation not due to any disagreement with company operations or policies.","Ciambrone will receive 2022 annual bonus and COBRA coverage through consulting period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-275897","json":"https://secwatch.observer/filing/0001193125-22-275897.json","markdown":"https://secwatch.observer/filing/0001193125-22-275897.md","text":"https://secwatch.observer/filing/0001193125-22-275897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/d393292d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T16:20:59.491347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"269ba3a8b1","claim":"Bilal Arif was appointed as Chief Technical Operations Officer at Sarepta Therapeutics, Inc..","evidence_excerpt":"On October 31, 2022, the Board appointed Bilal Arif, the Company’s Senior Vice President, Strategy and Operations, as the Company’s Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone’s retirement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Technical Operations Officer"}],"fact_type":"executive_change"},{"claim_id":"af7a8a3076","claim":"William F. Ciambrone resigned as Executive Vice President, Technical Operations at Sarepta Therapeutics, Inc..","evidence_excerpt":"On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the “Company”) of his resignation from his position as the Company’s Executive Vice President, Technical Operations, effective as of December 31, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President, Technical Operations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}